Home › Calculator › SBMFF Dividend Calculator 2026
SBMFF DRIP Calculator & Dividend Yield 2026
1.92% YieldHealthcareSino Biopharmaceutical Limited · OTC
Price: $0.67 · Annual div: $0.0128/share · Frequency: annual · Payout ratio: 10% · Ex-div: 2026-09-03
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SBMFF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
SBMFF Dividend History — Last 59 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-03Latest | 2026-09-24 | $0.0089 | 2.07% | $0.74 |
| 2026-06-26 | 2026-07-20 | $0.0064 | 2.02% | $0.63 |
| 2025-09-02 | 2025-09-23 | $0.0064 | 1.55% | $0.99 |
| 2025-06-18 | 2025-07-10 | $0.0051 | 1.59% | $0.56 |
| 2024-09-12 | 2024-10-04 | $0.0038 | 2.68% | $0.38 |
| 2024-06-13 | 2024-07-05 | $0.0038 | 3.84% | $0.37 |
| 2023-10-04 | 2023-10-27 | $0.0026 | 3.19% | $0.32 |
| 2023-06-20 | 2023-07-18 | $0.0077 | 3.12% | $0.49 |
| 2022-09-06 | 2022-09-28 | $0.0076 | 2.69% | $0.57 |
| 2022-06-16 | 2022-07-12 | $0.0051 | 2.39% | $0.54 |
| 2021-09-14 | 2021-10-04 | $0.0026 | 1.22% | $0.85 |
| 2021-06-21 | 2021-07-12 | $0.0052 | 0.96% | $1.08 |
| 2020-12-14 | 2020-12-31 | $0.0026 | — | — |
| 2020-09-14 | 2020-09-30 | $0.0026 | — | — |
| 2020-06-15 | 2020-07-06 | $0.0035 | — | — |
| 2019-12-10 | 2019-12-27 | $0.0017 | — | — |
| 2019-09-12 | 2019-09-30 | $0.0017 | — | — |
| 2019-06-14 | 2019-07-05 | $0.0035 | — | — |
| 2018-12-05 | 2018-12-21 | $0.0017 | — | — |
| 2018-09-11 | 2018-09-28 | $0.0017 | — | — |
| 2018-06-04 | 2018-06-25 | $0.0033 | — | — |
| 2017-11-28 | 2017-12-15 | $0.0013 | — | — |
| 2017-09-12 | 2017-09-29 | $0.0017 | — | — |
| 2017-07-06 | 2017-07-20 | $0.0013 | — | — |
| 2016-12-05 | 2016-12-19 | $0.0009 | — | — |
| 2016-09-12 | 2016-09-29 | $0.0009 | — | — |
| 2016-06-28 | 2016-07-13 | $0.0009 | — | — |
| 2015-12-03 | 2015-12-18 | $0.0004 | — | — |
| 2015-09-10 | 2015-09-25 | $0.0006 | — | — |
| 2015-06-19 | 2015-07-03 | $0.0006 | — | — |
| 2014-12-02 | 2014-12-18 | $0.0006 | — | — |
| 2014-09-11 | 2014-09-26 | $0.0006 | — | — |
| 2014-06-19 | 2014-07-04 | $0.0006 | — | — |
| 2013-12-02 | 2013-12-18 | $0.0003 | — | — |
| 2013-09-16 | 2013-09-27 | $0.0009 | — | — |
| 2013-06-13 | 2013-06-26 | $0.0009 | — | — |
| 2012-12-04 | 2012-12-18 | $0.0009 | — | — |
| 2012-09-11 | 2012-09-25 | $0.0009 | — | — |
| 2012-06-12 | 2012-06-25 | $0.0009 | — | — |
| 2011-12-06 | 2011-12-16 | $0.0017 | — | — |
| 2011-09-12 | 2011-09-26 | $0.0017 | — | — |
| 2011-06-09 | 2011-06-22 | $0.0017 | — | — |
| 2010-12-02 | 2010-12-17 | $0.0017 | — | — |
| 2010-09-08 | 2010-09-20 | $0.0017 | — | — |
| 2010-06-14 | 2010-06-25 | $0.0017 | — | — |
| 2009-09-24 | 2009-10-14 | $0.0013 | — | — |
| 2009-06-03 | 2009-06-17 | $0.0017 | — | — |
| 2008-12-03 | 2008-12-19 | $0.0009 | — | — |
| 2008-09-18 | 2008-10-08 | $0.0013 | — | — |
| 2008-06-18 | 2008-06-30 | $0.0017 | — | — |
| 2007-11-28 | 2007-12-10 | $0.0013 | — | — |
| 2007-09-19 | 2007-10-09 | $0.0013 | — | — |
| 2007-06-12 | 2007-06-22 | $0.0017 | — | — |
| 2006-09-29 | 2006-10-16 | $0.0009 | — | — |
| 2006-06-08 | 2006-06-19 | $0.0009 | — | — |
| 2005-11-25 | 2005-12-08 | $0.0433 | — | — |
| 2005-10-13 | 2005-10-26 | $0.0013 | — | — |
| 2005-10-13 | 2005-10-26 | $0.0013 | — | — |
| 2004-09-16 | 2004-09-30 | $0.0133 | — | — |
About Sino Biopharmaceutical Limited (SBMFF) — Dividend Analysis 2026
Sino Biopharmaceutical Limited is an investment holding company that operates as an integrated pharmaceutical enterprise. It researches, develops, manufactures, and markets a wide range of modernized Chinese medicines and chemical medicines. The company's therapeutic areas of focus include oncology, liver disease, respiratory, and surgery/pain relief, with its primary market being mainland China. [9, 12, 15, 19]
Similar dividend stocks to SBMFF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SBMFF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SBMFF position with:
🌍 SBMFF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SBMFF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.92% | -0.88% | $192 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.63% | -1.17% | $163 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.54% | -1.26% | $154 / yr |
| 🇬🇧 UK ISA | 0% | 1.92% | -0.88% | $192 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.75% | -1.05% | $175 / yr |
| 🇨🇦 TFSA | 0% | 1.92% | -0.88% | $192 / yr |
| 🇨🇦 CA Taxable | 25% | 1.44% | -1.36% | $144 / yr |
| 🇦🇺 Super (pension) | 15% | 1.63% | -1.17% | $163 / yr |
| 🇦🇺 AU Taxable | 30% | 1.34% | -1.46% | $134 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.41% | -1.39% | $141 / yr |
| 🇫🇷 FR Taxable | 30% | 1.34% | -1.46% | $134 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SBMFF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.01/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SBMFF Dividend Payment Schedule
SBMFF pays quarterly — 4 times per year. Ex-div: 2026-09-03.
📊 SBMFF vs Healthcare Benchmarks
How SBMFF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SBMFF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SBMFF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare SBMFF with peers: SBMFF vs AKTX · SBMFF vs AXLA · SBMFF vs BCDA
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SBMFF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Sino Biopharmaceutical Limited (SBMFF) is currently trading at $0.67, 25% below its 52-week high. The current dividend yield is 1.92% based on an annual payout of $0.0128 per share.
SBMFF (Sino Biopharmaceutical Limited) — 1.92% Dividend Yield Analysis
Sino Biopharmaceutical Limited (SBMFF) is a healthcare stock currently trading at $0.67 with a dividend yield of 1.92%. It pays an annual dividend of $0.0128 per share. The payout ratio of 10% suggests the dividend is well-covered by earnings. Over the past 5 years, SBMFF has grown its dividend at a compound annual rate of 5.7%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SBMFF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the SBMFF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.